Apparently UBS have a buy recommendation and a target of 430cents. That would seem closer to where this should be in my mind.Does anyone have more detail?
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game